• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Complications of living donor hepatic lobectomy--a comprehensive report.活体肝部分切除术的并发症——全面报告。
Am J Transplant. 2012 May;12(5):1208-17. doi: 10.1111/j.1600-6143.2011.03972.x. Epub 2012 Feb 15.
2
Donor morbidity after living donation for liver transplantation.活体肝移植供体的术后并发症
Gastroenterology. 2008 Aug;135(2):468-76. doi: 10.1053/j.gastro.2008.04.018. Epub 2008 Apr 22.
3
Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors.活体肝移植供者评估结果:单中心 132 例供者分析。
Hepatobiliary Pancreat Dis Int. 2011 Oct;10(5):480-8. doi: 10.1016/s1499-3872(11)60082-9.
4
Donor safety in living donor liver donation: An Italian multicenter survey.活体肝移植中供体的安全性:一项意大利多中心调查。
Liver Transpl. 2017 Feb;23(2):184-193. doi: 10.1002/lt.24651. Epub 2016 Dec 30.
5
Donor morbidity including biliary complications in living-donor liver transplantation: single-center analysis of 827 cases.供体发病率包括活体肝移植中的胆系并发症:827 例单中心分析。
Transplantation. 2012 May 15;93(9):942-8. doi: 10.1097/TP.0b013e31824ad5de.
6
Complications after Living Donor Hepatectomy: Analysis of 176 Cases at a Single Center.活体肝移植术后并发症:单中心 176 例分析。
J Am Coll Surg. 2018 Jul;227(1):24-36. doi: 10.1016/j.jamcollsurg.2018.03.007. Epub 2018 Mar 17.
7
Donor safety in living donor liver transplantation: The Korean organ transplantation registry study.活体肝移植中供体的安全性:韩国器官移植登记研究
Liver Transpl. 2017 Aug;23(8):999-1006. doi: 10.1002/lt.24778.
8
Three-quarters of right liver donors experienced postoperative complications.四分之三的右肝供体经历了术后并发症。
Liver Transpl. 2007 Jun;13(6):797-806. doi: 10.1002/lt.21030.
9
Donor Complications Following Living Donor Hepatectomy: 17-Year Experience of a Single Team in One Institution of Japan.活体肝切除术后供体并发症:日本某机构单一团队的17年经验
Exp Clin Transplant. 2024 Mar;22(3):223-228. doi: 10.6002/ect.2024.0026.
10
Surgery-related morbidity in living donors for liver transplantation.肝移植活体供者相关手术并发症。
Transplantation. 2010 May 27;89(10):1276-82. doi: 10.1097/TP.0b013e3181d66c55.

引用本文的文献

1
Modern approach to hepatocellular carcinoma treatment.肝细胞癌治疗的现代方法。
World J Hepatol. 2025 Aug 27;17(8):107873. doi: 10.4254/wjh.v17.i8.107873.
2
Novel Viral Sequences in a Patient with Cryptogenic Liver Cirrhosis Revealed by Serum Virome Sequencing.血清病毒组测序揭示隐源性肝硬化患者中的新型病毒序列
Viruses. 2025 Jun 3;17(6):812. doi: 10.3390/v17060812.
3
Dexmedetomidine Cannot Attenuate Liver Injury and Improve Outcomes Following Laparoscopic Living Donor Hepatectomy: A Randomised Controlled Trial.右美托咪定不能减轻活体供肝腹腔镜肝切除术后的肝损伤及改善预后:一项随机对照试验
Drug Des Devel Ther. 2025 May 22;19:4263-4274. doi: 10.2147/DDDT.S524343. eCollection 2025.
4
Minimally Invasive Donor Hepatectomy.微创供体肝切除术
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102516. doi: 10.1016/j.jceh.2025.102516. Epub 2025 Feb 19.
5
Living-Donor Liver Transplantation-The Need for Greater Transparency.活体肝移植——更高透明度的必要性
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102507. doi: 10.1016/j.jceh.2025.102507. Epub 2025 Jan 21.
6
First case of laparoscopic donor hepatectomy in Türkiye.土耳其首例腹腔镜供体肝切除术。
Turk J Surg. 2024 Dec 27;40(4):357-360. doi: 10.47717/turkjsurg.2022.5062. eCollection 2024 Dec.
7
Surgical treatment for hepatocellular carcinoma in era of multidisciplinary strategies.多学科策略时代的肝细胞癌外科治疗
Int J Clin Oncol. 2025 Mar;30(3):417-426. doi: 10.1007/s10147-025-02703-7. Epub 2025 Feb 5.
8
Chinese guidelines for minimally invasive donor hepatectomy in living donor liver transplantation (2024 edition).《中国活体肝移植供体微创肝切除术指南(2024年版)》
Hepatobiliary Surg Nutr. 2024 Dec 1;13(6):919-936. doi: 10.21037/hbsn-24-329. Epub 2024 Nov 20.
9
American perspectives for LDLT in 2024.2024年美国活体肝移植的前景
Updates Surg. 2024 Sep 20. doi: 10.1007/s13304-024-01994-1.
10
Non-Maleficence toward Young Kidney Donors: A Call for Stronger Ethical Standards and Associated Factors in Multidisciplinary Nephrology Teams.对年轻肾脏捐赠者的不伤害原则:呼吁多学科肾脏病团队制定更严格的伦理标准及相关因素
Nurs Rep. 2024 Aug 19;14(3):1998-2013. doi: 10.3390/nursrep14030149.

本文引用的文献

1
Adult living liver donors have excellent long-term medical outcomes: the University of Toronto liver transplant experience.成人活体肝移植供者具有优异的长期医疗结局:多伦多大学肝移植经验。
Am J Transplant. 2010 Feb;10(2):364-71. doi: 10.1111/j.1600-6143.2009.02950.x.
2
Surgery-related morbidity in living donors for liver transplantation.肝移植活体供者相关手术并发症。
Transplantation. 2010 May 27;89(10):1276-82. doi: 10.1097/TP.0b013e3181d66c55.
3
Intraoperative 'no go' donor hepatectomies in living donor liver transplantation.活体肝移植术中的“不行”供肝切除术。
Am J Transplant. 2010 Mar;10(3):612-8. doi: 10.1111/j.1600-6143.2009.02979.x. Epub 2010 Jan 29.
4
Response to letter "Systematic grading of morbidity after living donation for liver transplantation".对信件《活体肝移植术后发病率的系统分级》的回复
Gastroenterology. 2009 Nov;137(5):1855-6; author reply 1856-7. doi: 10.1053/j.gastro.2009.05.071. Epub 2009 Sep 30.
5
Complications of right lobe living donor liver transplantation.右叶活体供肝肝移植的并发症
J Hepatol. 2009 Oct;51(4):715-24. doi: 10.1016/j.jhep.2009.04.023. Epub 2009 May 27.
6
Donor morbidity after living donation for liver transplantation.活体肝移植供体的术后并发症
Gastroenterology. 2008 Aug;135(2):468-76. doi: 10.1053/j.gastro.2008.04.018. Epub 2008 Apr 22.
7
Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation.活体肝移植右肝叶供体的严重精神问题。
Transplantation. 2007 Jun 15;83(11):1506-8. doi: 10.1097/01.tp.0000263343.21714.3b.
8
Incisional hernias. I. Related risk factors.切口疝。一、相关危险因素。
Dig Surg. 2003;20(1):3-9. doi: 10.1159/000068850.
9
Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation.实体器官移植中不良结局的定义与分类。在肝移植中的应用。
Ann Surg. 1994 Aug;220(2):109-20. doi: 10.1097/00000658-199408000-00002.
10
Proposed classification of complications of surgery with examples of utility in cholecystectomy.手术并发症的拟议分类及在胆囊切除术中的应用实例
Surgery. 1992 May;111(5):518-26.

活体肝部分切除术的并发症——全面报告。

Complications of living donor hepatic lobectomy--a comprehensive report.

机构信息

Comprehensive Transplant Center, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

出版信息

Am J Transplant. 2012 May;12(5):1208-17. doi: 10.1111/j.1600-6143.2011.03972.x. Epub 2012 Feb 15.

DOI:10.1111/j.1600-6143.2011.03972.x
PMID:22335782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3732171/
Abstract

A wider application of living donor liver transplantation is limited by donor morbidity concerns. An observational cohort of 760 living donors accepted for surgery and enrolled in the Adult-to-Adult Living Donor Liver Transplantation cohort study provides a comprehensive assessment of incidence, severity and natural history of living liver donation (LLD) complications. Donor morbidity (assessed by 29 specific complications), predictors, time from donation to complications and time from complication onset to resolution were measured outcomes over a 12-year period. Out of the 760 donor procedures, 20 were aborted and 740 were completed. Forty percent of donors had complications (557 complications among 296 donors), mostly Clavien grades 1 and 2. Most severe counted by complication category; grade 1 (minor, n = 232); grade 2 (possibly life-threatening, n = 269); grade 3 (residual disability, n = 5) and grade 4 (leading to death, n = 3). Hernias (7%) and psychological complications (3%) occurred >1 year postdonation. Complications risk increased with transfusion requirement, intraoperative hypotension and predonation serum bilirubin, but did not decline with the increased center experience with LLD. The probability of complication resolution within 1 year was overall 95%, but only 75% for hernias and 42% for psychological complications. This report comprehensively quantifies LLD complication risk and should inform decision making by potential donors and their caregivers.

摘要

活体肝移植的广泛应用受到供体发病率的限制。一项观察性队列研究纳入了 760 名接受手术的活体供者,并登记在成人对成人活体肝移植队列研究中,全面评估了活体肝捐赠(LLD)并发症的发生率、严重程度和自然病程。供体发病率(通过 29 种特定并发症评估)、预测因素、从捐赠到并发症的时间以及从并发症开始到解决的时间是 12 年内的测量结果。在 760 例供者手术中,20 例被中止,740 例完成。40%的供者发生了并发症(296 名供者中有 557 例并发症),主要为 Clavien 1 级和 2 级。按并发症类别计算最严重的并发症;1 级(轻微,n=232);2 级(可能危及生命,n=269);3 级(残留残疾,n=5)和 4 级(导致死亡,n=3)。疝(7%)和心理并发症(3%)发生在捐赠后 1 年以上。并发症风险随着输血需求、术中低血压和预捐血清胆红素的增加而增加,但随着 LLD 中心经验的增加而不降低。1 年内并发症解决的概率总体为 95%,但疝为 75%,心理并发症为 42%。本报告全面量化了 LLD 并发症风险,应能为潜在供者及其护理人员的决策提供信息。